מאמרים עם הרשאות לגישה ציבורית - Shaker Mousaלמידע נוסף
לא זמינים באתר כלשהו: 3
Emerging roles for von Willebrand factor in cancer cell biology
JM O'Sullivan, RJS Preston, T Robson, JS O'Donnell
Seminars in thrombosis and hemostasis 44 (02), 159-166, 2018
הרשאות: UK Medical Research Council
Direct medical costs of breast cancer in Jordan: cost drivers and predictors
R Mousa, E Hammad, J Melhem, M Al-Jaghbir
Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 647-654, 2021
הרשאות: UK Medical Research Council, National Research Foundation, South Africa
Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia
TA Salaheldin, K Godugu, DJ Bharali, K Fujioka, N Elshourbagy, ...
Nanomedicine: Nanotechnology, Biology and Medicine 40, 102480, 2022
הרשאות: US National Institutes of Health
זמינים באתר כלשהו: 55
Omega-3 fatty acids EPA and DHA: health benefits throughout life
D Swanson, R Block, SA Mousa
Advances in nutrition 3 (1), 1-7, 2012
הרשאות: US National Institutes of Health
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins
Y Xu, S Masuko, M Takieddin, H Xu, R Liu, J Jing, SA Mousa, RJ Linhardt, ...
Science 334 (6055), 498-501, 2011
הרשאות: US National Institutes of Health
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate
IA Siddiqui, VM Adhami, DJ Bharali, BB Hafeez, M Asim, SI Khwaja, ...
Cancer research 69 (5), 1712-1716, 2009
הרשאות: US National Institutes of Health
Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities
MM Kemp, A Kumar, S Mousa, TJ Park, P Ajayan, N Kubotera, SA Mousa, ...
Biomacromolecules 10 (3), 589-595, 2009
הרשאות: US National Institutes of Health
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
N Khan, DJ Bharali, VM Adhami, IA Siddiqui, H Cui, SM Shabana, ...
Carcinogenesis 35 (2), 415-423, 2014
הרשאות: US National Institutes of Health
Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects
DJ Bharali, IA Siddiqui, VM Adhami, JC Chamcheu, AM Aldahmash, ...
Cancers 3 (4), 4024-4045, 2011
הרשאות: US National Institutes of Health
RETRACTED ARTICLE: Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
SA Loutfy, MH Elberry, KY Farroh, HT Mohamed, AA Mohamed, ...
International journal of nanomedicine, 2699-2715, 2020
הרשאות: US National Institutes of Health
Hyaluronan-and heparin-reduced silver nanoparticles with antimicrobial properties
MM Kemp, A Kumar, D Clement, P Ajayan, S Mousa, RJ Linhardt
Nanomedicine 4 (4), 421-429, 2009
הרשאות: US National Institutes of Health
Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis
B Yang, A Weyers, JY Baik, E Sterner, S Sharfstein, SA Mousa, F Zhang, ...
Analytical biochemistry 415 (1), 59-66, 2011
הרשאות: US National Institutes of Health
Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells
V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, ...
Oncotarget 7 (31), 50365, 2016
הרשאות: US National Institutes of Health
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
DJ Bharali, M Yalcin, PJ Davis, SA Mousa
Nanomedicine 8 (12), 1943-1954, 2013
הרשאות: US National Institutes of Health
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
DJ Bharali, V Pradhan, G Elkin, W Qi, A Hutson, SA Mousa, Y Thanavala
Nanomedicine: Nanotechnology, Biology and Medicine 4 (4), 311-317, 2008
הרשאות: US National Institutes of Health
Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity
J Suwan, Z Zhang, B Li, P Vongchan, P Meepowpan, F Zhang, SA Mousa, ...
Carbohydrate research 344 (10), 1190-1196, 2009
הרשאות: US National Institutes of Health
Control of the heparosan N-deacetylation leads to an improved bioengineered heparin
Z Wang, B Yang, Z Zhang, M Ly, M Takieddin, S Mousa, J Liu, JS Dordick, ...
Applied microbiology and biotechnology 91, 91-99, 2011
הרשאות: US National Institutes of Health
Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
JC Chamcheu, IA Siddiqui, VM Adhami, S Esnault, DJ Bharali, ...
International journal of nanomedicine, 4189-4206, 2018
הרשאות: US National Institutes of Health
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism
X Zheng, F Chu, PM Chou, C Gallati, U Dier, BL Mirkin, SA Mousa, ...
American Journal of Physiology-Cell Physiology 296 (1), C65-C74, 2009
הרשאות: US National Institutes of Health
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids
N Golub, D Geba, SA Mousa, G Williams, RC Block
Medical hypotheses 77 (6), 1114-1120, 2011
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב